154 related articles for article (PubMed ID: 30509492)
1. SR 57227A is a partial agonist/partial antagonist of 5-HT
Nakamura Y; Kondo M; Koyama Y; Shimada S
Biochem Biophys Res Commun; 2019 Jan; 508(2):590-596. PubMed ID: 30509492
[TBL] [Abstract][Full Text] [Related]
2. A single channel mutation alters agonist efficacy at 5-HT3A and 5-HT3AB receptors.
Thompson AJ; Lummis SC
Br J Pharmacol; 2013 Sep; 170(2):391-402. PubMed ID: 23822584
[TBL] [Abstract][Full Text] [Related]
3. SR 57227A: a potent and selective agonist at central and peripheral 5-HT3 receptors in vitro and in vivo.
Bachy A; Héaulme M; Giudice A; Michaud JC; Lefevre IA; Souilhac J; Manara L; Emerit MB; Gozlan H; Hamon M
Eur J Pharmacol; 1993 Jun; 237(2-3):299-309. PubMed ID: 7689975
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of NMDA-receptor mediated response in the rat medial prefrontal cortical pyramidal cells by the 5-HT3 receptor agonist SR 57227A and 5-HT: intracellular studies.
Liang X; Arvanov VL; Wang RY
Synapse; 1998 Jul; 29(3):257-68. PubMed ID: 9635896
[TBL] [Abstract][Full Text] [Related]
5. Direct modification of the 5-HT
Nakamura Y; Ishida Y; Kondo M; Shimada S
Eur J Pharmacol; 2018 Feb; 821():21-28. PubMed ID: 29277715
[TBL] [Abstract][Full Text] [Related]
6. Subunit-dependent inhibition and potentiation of 5-HT3 receptor by the anticancer drug, topotecan.
Nakamura Y; Ishida Y; Yamada T; Kondo M; Shimada S
J Neurochem; 2013 Apr; 125(1):7-15. PubMed ID: 23305320
[TBL] [Abstract][Full Text] [Related]
7. Yokukansan contains compounds that antagonize the 5-HT
Nakamura Y; Ishida Y; Kondo M; Shimada S
Phytomedicine; 2018 Apr; 43():120-125. PubMed ID: 29747744
[TBL] [Abstract][Full Text] [Related]
8. Endogenous cannabinoid, anandamide, acts as a noncompetitive inhibitor on 5-HT3 receptor-mediated responses in Xenopus oocytes.
Oz M; Zhang L; Morales M
Synapse; 2002 Dec; 46(3):150-6. PubMed ID: 12325042
[TBL] [Abstract][Full Text] [Related]
9. Delineation of the functional properties and the mechanism of action of TMPPAA, an allosteric agonist and positive allosteric modulator of 5-HT3 receptors.
Gasiorek A; Trattnig SM; Ahring PK; Kristiansen U; Frølund B; Frederiksen K; Jensen AA
Biochem Pharmacol; 2016 Jun; 110-111():92-108. PubMed ID: 27086281
[TBL] [Abstract][Full Text] [Related]
10. Bupropion Inhibits Serotonin Type 3AB Heteromeric Channels at Clinically Relevant Concentrations.
Stuebler AG; Jansen M
Mol Pharmacol; 2020 Mar; 97(3):171-179. PubMed ID: 31871303
[TBL] [Abstract][Full Text] [Related]
11. Subtle Differences among 5-HT
Price KL; Hirayama Y; Lummis SCR
ACS Chem Neurosci; 2017 May; 8(5):1085-1091. PubMed ID: 28367632
[TBL] [Abstract][Full Text] [Related]
12. The multimodal antidepressant vortioxetine may facilitate pyramidal cell firing by inhibition of 5-HT
Dale E; Grunnet M; Pehrson AL; Frederiksen K; Larsen PH; Nielsen J; Stensbøl TB; Ebert B; Yin H; Lu D; Liu H; Jensen TN; Yang CR; Sanchez C
Brain Res; 2018 Jun; 1689():1-11. PubMed ID: 29274875
[TBL] [Abstract][Full Text] [Related]
13. The nonpsychoactive cannabinoid cannabidiol inhibits 5-hydroxytryptamine3A receptor-mediated currents in Xenopus laevis oocytes.
Yang KH; Galadari S; Isaev D; Petroianu G; Shippenberg TS; Oz M
J Pharmacol Exp Ther; 2010 May; 333(2):547-54. PubMed ID: 20160007
[TBL] [Abstract][Full Text] [Related]
14. Superagonist, Full Agonist, Partial Agonist, and Antagonist Actions of Arylguanidines at 5-Hydroxytryptamine-3 (5-HT
Alix K; Khatri S; Mosier PD; Casterlow S; Yan D; Nyce HL; White MM; Schulte MK; Dukat M
ACS Chem Neurosci; 2016 Nov; 7(11):1565-1574. PubMed ID: 27533595
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a 5-HT
Price KL; Lummis SCR
ACS Chem Neurosci; 2018 Jun; 9(6):1409-1415. PubMed ID: 29508995
[TBL] [Abstract][Full Text] [Related]
16. In vivo modulation of the firing activity of putative slow- and fast-spiking interneurons in the medial prefrontal cortex by 5-HT3 receptors in 6-hydroxydopamine-induced Parkinsonian rats.
Gui ZH; Zhang QJ; Liu J; Ali U; Li LB; Wang Y; Wang T; Chen L; Hou C; Fan LL
Neuroscience; 2010 Sep; 169(3):1315-25. PubMed ID: 20576497
[TBL] [Abstract][Full Text] [Related]
17. Importance of recognition loops B and D in the activation of human 5-HT₃ receptors by 5-HT and meta-chlorophenylbiguanide.
Michaelson SD; Paulsen IM; Kozuska JL; Martin IL; Dunn SM
Neuropharmacology; 2013 Oct; 73():398-403. PubMed ID: 23810831
[TBL] [Abstract][Full Text] [Related]
18. Effects of ginsenoside Rg2 on the 5-HT3A receptor-mediated ion current in Xenopus oocytes.
Choi S; Lee JH; Oh S; Rhim H; Lee SM; Nah SY
Mol Cells; 2003 Feb; 15(1):108-13. PubMed ID: 12661769
[TBL] [Abstract][Full Text] [Related]
19. Antidepressant-like effects of SR 57227A, a 5-HT3 receptor agonist, in rodents.
Poncelet M; Perio A; Simiand J; Gout G; Soubrie P; Le Fur G
J Neural Transm Gen Sect; 1995; 102(2):83-90. PubMed ID: 8748673
[TBL] [Abstract][Full Text] [Related]
20. Anticancer drug irinotecan inhibits homomeric 5-HT3A and heteromeric 5-HT3AB receptor responses.
Nakamura Y; Ishida Y; Yamada T; Shimada S
Biochem Biophys Res Commun; 2011 Nov; 415(2):416-20. PubMed ID: 22044840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]